SOLEUS CAPITAL MANAGEMENT, L.P. – Alnylam Pharmaceuticals, Inc. Transaction History
SOLEUS CAPITAL MANAGEMENT, L.P. portfolio value:
$5.40M
portfolio value
SOLEUS CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +34.33% | 6.9K shares | 2.47M | $200.16 | 27K |
Q2 2022 | share | Increase | 0.00% | 20.1K shares | 2.93M | $145.85 | 20.1K |